Academic Programmes

Academic Programmes

First Injectable Matters: A SOLID Approach to Fixed-Ratio Combination Therapy – ICON+ Insulin Conversations by Sanofi

2 September, 2026

Academic Programmes

The ONWARDS Story: Awiqli® Evidence – Novo Nordisk

26 August, 2026

Academic Programmes

Navigating the Obesity Journey: Towards Lighter, Healthier, Happier Lives – Regional Metabolic Forum

25 August, 2026

Academic Programmes

Semaglutide for Every T2DM Patient? Where Should We Draw the Line? – TOBE Leadership Conclave 2026

22 August, 2026

Academic Programmes

Contemporary Evidence with GLP-1RAs in People Living with MASH – Wegovy 3SP Multispecialty Meeting

20 August, 2026

Academic Programmes

ESSENCE UNVEILED – Transforming MASH Management with the Innovator Semaglutide – LAICON 2026

16 August, 2026

Academic Programmes

Advancing Diabetes Management with Connected CGM – CME by Abbott India

14 August, 2026

Academic Programmes

AWIQLI Medical Briefing – CME by Novo Nordisk

2 August, 2026

Academic Programmes

Act Early & Think Holistically in the Treatment of T2D – 4th Ajajmeru Diabetes Summit

1 August, 2026

Academic Programmes

Evolving Metabolic Outcome with Semaglutide – What a Clinician Should Know in 2026 – CME by Alkem

1 August, 2026

Academic Programmes

Innovator Semaglutide: Translating Cardiometabolic Evidence into Practice – Wegovy 3SP Multispecialty Meeting

25 July, 2026

Academic Programmes

Pharmacotherapy of POCS with reference to obesity – CME by Novo

5 July, 2026